Mechanisms accounting for FOXM1 overexpression in cancer cells and tissues are diverse and include p53, Rb, and FOXO3 loss [13–16], Myc, HIF-1, Gli1, SP1, STAT3 and E2F activation [17–22], and gene amplification [23]. Here, MYC is linked to cancer.